Cite

HARVARD Citation

    Hirai, I. et al. (2021). Adoptive cell therapy using tumor‐infiltrating lymphocytes for melanoma refractory to immune‐checkpoint inhibitors. Cancer science. 112 (8), pp. 3163-3172. [Online]. 
  
Back to record